Literature DB >> 22180290

Concentration of hospital care for acute sickle cell disease-related visits.

J A Panepinto1, P L Owens, A L Mosso, C A Steiner, D C Brousseau.   

Abstract

BACKGROUND: Sickle cell disease (SCD) is characterized by frequent disease-related events that require acute care. It is unknown to what extent patients utilize multiple hospitals for acute care. We examined the continuity pattern of acute care visits to the hospital or emergency department. We hypothesized that among patients with multiple SCD related acute care visits, children experience more concentrated hospital care than adults and privately insured patients experience more concentrated hospital care than publicly insured patients. PROCEDURE: We conducted a retrospective cohort study using data from the 2005 and 2006 Healthcare Cost and Utilization Project State Inpatient Databases and State Emergency Department Databases. Subjects included patients with SCD ≥ 1 year of age. The primary outcome was proportion of patients with multiple acute care visits to a single hospital.
RESULTS: A total of 13,533 patients made ≥ 2 acute SCD-related visits. Of the 5,030 children, 77.3% went to the same hospital for all visits. In contrast, of the 8,503 adults, only 51.3% visited the same hospital. Adolescents were more likely than adults to go to one hospital [adjusted relative risk (ARR) 1.40, confidence interval (CI) 1.35-1.45]. Those with public insurance and the uninsured had a decreased probability of using one hospital (ARR 0.96, CI 0.94-0.99, and ARR 0.83, CI 0.79-0.88, respectively).
CONCLUSIONS: Adults and patients with public insurance or no insurance are more likely to use multiple hospitals for acute care. By receiving acute care at multiple hospitals, patients with SCD experience dispersed and fragmented care potentially leading to decreased care quality.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22180290      PMCID: PMC3310931          DOI: 10.1002/pbc.24028

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  29 in total

1.  Sickle cell disease summit: from clinical and research disparity to action.

Authors:  Kathryn Hassell; Betty Pace; Winfred Wang; Roshni Kulkarni; Naomi Luban; Cage S Johnson; James Eckman; Peter Lane; William G Woods
Journal:  Am J Hematol       Date:  2009-01       Impact factor: 10.047

2.  Sickle cell disease standards tackle inequality in adult care.

Authors:  Ingrid Torjesen
Journal:  Nurs Times       Date:  2008 Jul 22-28

3.  Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.

Authors:  Julie A Panepinto; David C Brousseau; Cheryl A Hillery; J Paul Scott
Journal:  Pediatr Blood Cancer       Date:  2005-02       Impact factor: 3.167

4.  Building a medical neighborhood for the medical home.

Authors:  Elliott S Fisher
Journal:  N Engl J Med       Date:  2008-09-18       Impact factor: 91.245

5.  Medical home 2009: what it is, where we were, and where we are today.

Authors:  Charles J Homer; W Carl Cooley; Bonnie Strickland
Journal:  Pediatr Ann       Date:  2009-09       Impact factor: 1.132

6.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.

Authors:  J Zhang; K F Yu
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

7.  Sickle cell hospital unit: a disease-specific model.

Authors:  Patricia Adams-Graves; Elizabeth J Ostric; Mary Martin; Pat Richardson; James B Lewis
Journal:  J Healthc Manag       Date:  2008 Sep-Oct

8.  Patient satisfaction in specialized versus nonspecialized adult sickle cell care centers: the PiSCES study.

Authors:  Imoigele P Aisiku; Lynne T Penberthy; Wally R Smith; Viktor E Bovbjerg; Donna K McClish; James L Levenson; John D Roberts; Susan D Roseff
Journal:  J Natl Med Assoc       Date:  2007-08       Impact factor: 1.798

9.  Transition of patients with sickle cell disease from pediatric to adult care: Assessing patient readiness.

Authors:  Marianne McPherson; Lisa Thaniel; Caterina P Minniti
Journal:  Pediatr Blood Cancer       Date:  2009-07       Impact factor: 3.167

Review 10.  Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders.

Authors:  Scott D Grosse; Michael S Schechter; Roshni Kulkarni; Michele A Lloyd-Puryear; Bonnie Strickland; Edwin Trevathan
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  12 in total

1.  Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals.

Authors:  Jean L Raphael; Troy Richardson; Matt Hall; Suzette O Oyeku; David G Bundy; Ram V Kalpatthi; Samir S Shah; Angela M Ellison
Journal:  J Pediatr       Date:  2015-10-23       Impact factor: 4.406

2.  Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Authors:  Susan T Paulukonis; Lisa B Feuchtbaum; Thomas D Coates; Lynne D Neumayr; Marsha J Treadwell; Elliott P Vichinsky; Mary M Hulihan
Journal:  Pediatr Blood Cancer       Date:  2016-12-21       Impact factor: 3.167

3.  The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.

Authors:  Courtney D Fitzhugh; Mark C Walters
Journal:  Blood Adv       Date:  2017-12-08

Review 4.  Sickle cell disease and implementation science: A partnership to accelerate advances.

Authors:  Allison A King; Ana A Baumann
Journal:  Pediatr Blood Cancer       Date:  2017-05-28       Impact factor: 3.167

5.  Prevention of central nervous system sequelae in sickle cell disease without evidence from randomized controlled trials: the case for a team-based learning collaborative.

Authors:  Michael R DeBaun; Allison A King
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Neuropathic pain in patients with sickle cell disease.

Authors:  Amanda M Brandow; Rebecca A Farley; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2013-10-26       Impact factor: 3.167

7.  Emergency Department (ED), ED Observation, Day Hospital, and Hospital Admissions for Adults with Sickle Cell Disease.

Authors:  David M Cline; Susan Silva; Caroline E Freiermuth; Victoria Thornton; Paula Tanabe
Journal:  West J Emerg Med       Date:  2018-02-12

8.  Considerations When Aggregating Data to Measure Performance Across Levels of the Health Care System.

Authors:  Sarah L Reeves; Kevin J Dombkowski; Brian Madden; Lindsay Cogan; Shanshan Liu; Paul B Kirby; Sara L Toomey
Journal:  Acad Pediatr       Date:  2022-04       Impact factor: 2.993

9.  State-based surveillance for selected hemoglobinopathies.

Authors:  Mary M Hulihan; Lisa Feuchtbaum; Lanetta Jordan; Russell S Kirby; Angela Snyder; William Young; Yvonne Greene; Joseph Telfair; Ying Wang; William Cramer; Ellen M Werner; Kristy Kenney; Melissa Creary; Althea M Grant
Journal:  Genet Med       Date:  2014-07-03       Impact factor: 8.822

10.  American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Authors:  M R DeBaun; L C Jordan; A A King; J Schatz; E Vichinsky; C K Fox; R C McKinstry; P Telfer; M A Kraut; L Daraz; F J Kirkham; M H Murad
Journal:  Blood Adv       Date:  2020-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.